Understanding membrane proteins using biomimetics

Biomimetics is a flourishing field in which scientists take inspiration from the natural world and our bodies systems to design sophisticated technologies. By developing tools that mimic what our bodies are able to do, researchers are providing unparalleled opportunities for the studies of molecular functioning and structure. Dr. Gerhard Wagner, Elkan Blout Professor of Biological Chemistry and Molecular Pharmacology at the Harvard Medical School, studies the structure, function, and interaction of proteins, in particular of membrane proteins, using biomimetics. In fact, he and his team develop and optimize nanodisc technology they have created as a near-native environment for integral membrane proteins which they can then use to study using either NMR spectroscopy or cyto-electron microscopy. Thus, Dr. Wagner’s studies offer a breakthrough in the study of membrane proteins and their complexes.

Dr. Wagner’s research combines structural biology with biology function and drug discovery. He continues to be at the forefront of technology development as he develops tools for membrane protein studies. His current research will provide the platform for studying integral membrane proteins in near-native bilayer environments in nanodiscs as an entirely new tool for studies of membrane protein structure and interaction. Therefore, Dr. Wagner’s research has the potential for facilitating discovery of new drugs. Furthermore, nanodisc inserted antigens may become new vehicles for vaccination that can be used to treat the untreatable. Dr. Wagner is well-funded for other projects by NIH therefore, he is unable to receive funding for this creative and innovative approach to drug discovery, and vaccine development; donations will enable his research to touch the lives of millions.

Current research includes:

  • Polio: Dr. Wagner and his team are studying the interaction between the poliovirus and a cellular membrane. By creating a nanodisc and decorating it with the receptor of a poliovirus, the poliovirus considers the nanodisc as a target cell, binds to it, and starts injecting its RNA through the nanodisc. He and his team can then study the nanodisc by collecting images of different stages of this process.

  • Energy Transport: The ADP/ATP transporter ANTI1 and Voltage-Dependent Anion Channel 1 is responsible for transporting energy from the mitochondrial matrix to the cytosol. Dr. Wagner and his team can place the two proteins into two different nanodiscs and study the complex with various sophisticated tools including NMR, EPR, and cryoEM.

  • Programmed Cell Death: Dr. Wagner’s imaging technologies have allowed him to shed light on the Bax pore in the outer mitochondrial membrane and complexes of VDAC1 with Bax or other cell death-related proteins. Given his research, he and his team are helping to understand the molecular mechanisms behind programmed cell death.

  • Drug Discovery: Studying GPCRs in nanodiscs will allow researchers to make revolutionary bounds in drug discovery. Dr. Wagner’s team can study interactions within the cell to elucidate mechanisms of signal transduction or to study interactions with several ligands. Additionally, new technology, developed in Dr. Wagner’s lab, allows his team to provide a totally new platform for screening for new drug targets.

Dr. Gerhard Wagner was the first to receive a college education in his family. Born to a blue-collar family, after WWII in the German-speaking part of Czechoslovakia, his family was forced to leave and ended up in Southern Bavaria where he grew up. Due to his school records he could go to a humanistic gymnasium, an institution that teaches classical antiquity specifically, and received an education with nine years of Latin and six years of classical Greek but also a good education in math and some physics. There, he had an excellent math/physics teacher and became fascinated with physics.

After graduation Dr. Wagner was drafted to German military service for 18 months. He studied physics at the Technical University of Munich. With his good grades, he received a fellowship from the Studienstiftung des Deutschen Volkes. Meetings with his fellowship advisors made him aware of the field of biophysics and he looked into doing something in that direction. Thus, for his Diploma thesis, he built a Mössbauer spectrometer and recorded 57Fe of hemoglobins, myoglobins and ferredoxins. From the temperature dependence of the quadrupolar splitting of 57Fe he could calculate the optical spectrum of hemoglobin including the Soret band.

However, Mössbauer spectroscopy is very insensitive, and one can measure a single parameter, the quadrupolar splitting, and its temperature dependence. At that time, Dr. Wagner’s diploma advisor went for a sabbatical at Bell labs (1972) where he learned about NMR spectroscopy from Robert Shulman. He communicated to Dr. Wagner that NMR spectra have many lines, compared to two in a Mössbauer spectrum. The Shulman lab had just discovered the paramagnetically shifted heme resonances of hemoglobin. Thus, he concluded this must be more interesting. The person who had discovered the heme resonances in the Shulman lab, Kurt Wüthrich, had just moved to the ETH Zürich. Thus he decided to pursue a Ph.D. in his lab and moved to Zürich beginning of 1973 although some of his Munich advisors told him that “everything has been done in NMR already.”

In Zürich he started to work with a small rigid protein, the basic pancreatic trypsin inhibitor, BPTI, for which the lab of Robert Huber in the Max-Planck Institute in Munich had just determined the highest resolution X-ray structure at 1.0 Å. Studying the temperature dependence of BPTI’s NMR spectrum he discovered that aromatic side chains undergo rapid 180 degree flips, and he could accelerate or slow down flip rates with temperature variation. This suggested spatial rearrangements of more than 1.7 Å and was entirely contradictory the view of protein structures at that time but changed the way structural biologists think about dynamic proteins now.

After graduation, he spent six months at the Chemistry department of MIT to explore solid state NMR. Afterwards he went back to the Wüthrich lab in Zürich to continue work on solution NMR of proteins. He learned about the nuclear Overhauser effect (nOe) and developed procedures for sequence specific resonance assignments of proteins. He was the first to completely assign the resonances of an entire protein (BPTI). This became the foundation of solving protein structures in solution by NMR. The first structure he determined was for rabbit metallothioneine 2. When he and his team were ready to publish it a crystal structure was reported for the same protein but was entirely different from his topology. After intensive scrutiny of his data it became clear that his structure was correct, and the crystal structure was not. This made the crystallographers aware of him, and he received offers for faculty positions at Duke, the University of Michigan, and the University of Minnesota. He accepted the position in Ann Arbor where he was hired as Associate Professor with tenure in 1987.

Already before his arrival in Michigan, he had ordered construction of a triple resonance probe for his new spectrometer. This allowed pulsing 1H, 15N and 13C. After the probe was delivered in 1988, he developed triple resonance methods for conformation-independent sequential assignments of proteins. This has become the basis for today’s resonance assignments of proteins and structure determination of proteins in solution up to 50 kDa and above. Due to this achievement, Dr. Wagner obtained an offer from Harvard Medical School where he has stayed since 1990.

At Harvard he has determined numerous structures (>50) of important proteins, primarily in the field of translation initiation, apoptosis and T-cell biology. He and his team have discovered small molecule inhibitors of protein-protein interactions and found some to have tumor suppressive activities. He believes that these can become powerful anti-cancer agents.

On the other hand, he has become excited by the structural and functional studies of integral membrane proteins. To this end, he and his team have developed a technology to place membrane proteins into covalently circularized phospholipid nanodiscs. Dr. Wagner can make nanodiscs of various size from 9 nm to 80 nm and place membrane proteins inside to be studied with NMR and electron microscopy. This includes whole GPCRs with associated G proteins, the whole T-cell receptor CD3 complex or an entire poliovirus injecting its RNA through the nanodisc. This is the most exciting recent achievement in Dr. Wagner’s lab.

Website: gwagner.med.harvard.edu

Elected Member to Deutsche Akademie der Naturforscher Leopoldina (German National Academy) , 2005

Elected Fellow to the International Society of Magnetic Resonance, 2008

Stein and Moore Award of the Protein Society, 2011

Elected member of the National Academy of Sciences (US), 2013

Elected member of the American Academy of Arts and Sciences, 2015